Search:

Cancer Therapy

The journal “Cancer Therapy” (www.cancer-therapy.org) encompasses various fields in Cancer. It does not apply any charges to authors for pages, color figures, reviewers fees, and is an open access without subscription passwords to all audiences.

The scope of Cancer Therapy is to rapidly publish original and in-depth review articles on cancer embracing all fields from molecular mechanisms to results on clinical trials. Articles (both invited and submitted) review or report novel findings of importance on cancer, from basic research to clinical results including drugs based on platinum compounds, antimicrotubule agents, antitumor antibiotics, alkylating agents, antimetabolites, antiangiogenesis, monoclonal antibodies, natural products, kinase inhibitors and others. Also, topics concerning natural products that have shown positive results with some types of cancer. Furthermore, the so long neglected subject of cancer immunotherapy which should be considered alongside surgery, chemotherapy and radiotherapy as the fourth cornerstone of anti-cancer treatment.

[ Index Copernicus ] Cancer Therapy - (ISSN 1543-9143) was positively evaluated in IC Journals Master List 2012, which resulted in score given ICV 6.37 points. (Index Copernicus Value). Detailed scoring can be found in the Detailed Report of the evaluation, which is attached. We invite you to familiarise yourself with the methodology of the IC Journals Master List.

---

Volume 10

(Currently in Development!) Manuscript Contributions Welcomed

Pages	Title
1-12	Signaling And Metabolism In Cancer: Endocrine Pancreas Deficiency And Hybrid Anabolism – Catabolism, Drugs That Undo The Process.
	Dr. Maurice , Israël
13-37	The therapeutic use of plants against critical human illnesses predates recorded history and represents the most significant direct antecedent to modern medicine. With the advances of various in-silico technologies, the introduction of plant derived bioactive agents into the cancer armamentarium has changed the natural history of many types of human cancer. In spite of numerous advances in the field of cancer research, the world still continues to be in the grip of this dreadful disease and there is an urgent need to design well tolerated anti-cancer therapeutic agents. Numerous plants have the potential of anticancer activity but are still to be investigated. However, existing flora is so vast that it is humanly impossible to investigate each and every plant for anti-cancer activity. Increasing global warming, malnutrition and various environmental insults continue to increase the incidences of cancer. “Cancer is hostile to human body and hostile environment is cancerous to plants”. Accordingly, those plants which are able to comfortably survive under multiple but diverse hostile environments may act as a vital source of anti-cancer agents. Moreover, these anticancer agents are likely to be safe by virtue of being of natural origin. Various plants reported/studied for anticancer activity till date have been briefly reviewed in the present article. An urgent need for screening plants surviving in diverse hostile environments for anticancer activity has been emphasized so as to accelerate development of effective but safe anticancer drugs.
	Dr. A.K. , Madan, R. Dutt, Vandana Garg and A.K. Madan
13-19	Metabolic cancer treatment: Intermediate results of a clinical study
	Dr. Laurent, Schwartz, Ludivine Buhler, Philippe Icard1, Hubert Lincet, Mireille Gettler Summa and Jean-Marc Steyaert,
20-27	The addition of chloroquine and metformine to Metabloc induces a rapid drop of tumor markers in advanced carcinoma
	Dr. Laurent, Schwartz, Jean Gabillet, Ludivine Buhler, Jean-Marc Steyaert

• Contribute an Article: Manuscript Pre-submission Form for Volume 10

---

---

Please give us your feedback:

If you would like, include your name and email somewhere in the text...